Details for Patent: 6,303,146

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,303,146

Title:	Solid oral dosage form comprising a combination of metformin and glibenclamide
Abstract:	The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
Inventor(s):	Bonhomme; Yves (Charbonnieres les Bains, FR), Nicholson; Geoffrey (Aylesbury, GB), Cave; Gillian (Ellesmere Port, GB), Nicholson; Sarah J. (Helsby, GB)
Assignee:	LIPHA (Lyons, FR)
Application Number:	09/353,141
Patent Claim Types: see list of patent claims	Compound; Dosage form; Composition; Process; Formulation; Use;

Drugs Protected by US Patent 6,303,146

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,303,146

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	98401781	Jul 15, 1998

International Family Members for US Patent 6,303,146

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1450	See Plans and Pricing
Argentina	013052	See Plans and Pricing
Argentina	065970	See Plans and Pricing
Austria	250418	See Plans and Pricing
Australia	2003261560	See Plans and Pricing
Australia	5417999	See Plans and Pricing
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.